Picture of Nascent Biotech logo

NBIO Nascent Biotech Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Nascent Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.37-4-0.959-0.47-2.8
Non-Cash Items0.2471.630.074-0.0271.33
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.411.82-0.1030.911-0.317
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-0.712-0.554-0.9870.413-1.79
Financing Cash Flow Items0.208
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.7260.4260.985-0.3211.86
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.014-0.128-0.0020.0930.078